Purchases and Sales Made in Q4 2024 in Lyra Therapeutics, Inc. (LYRA)
This table provides information about the institutional ownership of Lyra Therapeutics, Inc. (LYRA) during Q4 2024. The information is specifically focused on institutions that hold shares of Lyra Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2025
Q4 2024
|
Adar1 Capital Management, LLC
Austin, TX |
BUY
|
- |
533KNew |
$90.6K - $149K
|
533K
$4.86M
|
|
|
Feb 14, 2025
Q4 2024
|
Ubs Group Ag
|
BUY
|
- |
400K+ 1605.66% |
$68K - $112K
|
425K
$3.88M
|
|
|
Feb 14, 2025
Q4 2024
|
Qube Research & Technologies LTD
London, X0 |
BUY
|
- |
342KNew |
$58.2K - $95.8K
|
342K
$3.12M
|
|
|
Feb 12, 2025
Q4 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
118K+ 15.3% |
$20K - $32.9K
|
886K
$8.08M
|
|
|
Feb 14, 2025
Q4 2024
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
103K+ 56.21% |
$17.5K - $28.8K
|
286K
$2.61M
|
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
96.7K+ 161.78% |
$16.4K - $27.1K
|
156K
$1.43M
|
|
|
Feb 14, 2025
Q4 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
90.5K+ 700.98% |
$15.4K - $25.3K
|
103K
$943K
|
|
|
Feb 11, 2025
Q4 2024
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
42.1KNew |
$7.15K - $11.8K
|
42.1K
$384K
|
|
|
Feb 13, 2025
Q4 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
24.7K+ 163.08% |
$4.19K - $6.91K
|
39.8K
$363K
|
|
|
Jan 23, 2025
Q4 2024
|
Abel Hall, LLC
Baton Rouge, LA |
BUY
|
- |
17.6KNew |
$3K - $4.94K
|
17.6K
$161K
|
|
|
Feb 13, 2025
Q4 2024
|
Pro Share Advisors LLC
|
BUY
|
- |
13.6KNew |
$2.32K - $3.82K
|
13.6K
$124K
|
|
|
Feb 13, 2025
Q4 2024
|
Barclays PLC
London, X0 |
BUY
|
- |
12K+ 18.88% |
$2.03K - $3.35K
|
75.3K
$686K
|
|
|
Feb 11, 2025
Q4 2024
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
8.17K+ 1.49% |
$1.39K - $2.29K
|
556K
$5.07M
|
|
|
Feb 11, 2025
Q4 2024
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
8.16K+ 0.46% |
$1.39K - $2.28K
|
1.79M
$16.3M
|
|
|
Feb 12, 2025
Q4 2024
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
7.15K+ 40.62% |
$1.22K - $2K
|
24.7K
$226K
|
|
|
Feb 04, 2025
Q4 2024
|
Cwm, LLC
|
BUY
|
- |
4.63K+ 628.77% |
$788 - $1.3K
|
5.37K
$49K
|
|
|
Feb 05, 2025
Q4 2024
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
BUY
|
- |
4.27KNew |
$726 - $1.2K
|
4.27K
$38.9K
|
|
|
Feb 14, 2025
Q4 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
3.44K+ 6.98% |
$584 - $962
|
52.7K
$480K
|
|
|
Feb 12, 2025
Q4 2024
|
Citigroup Inc
|
BUY
|
- |
3.07K+ 8.75% |
$521 - $858
|
38.1K
$347K
|
|
|
Feb 14, 2025
Q4 2024
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
- |
1.32K+ 0.57% |
$224 - $369
|
234K
$2.13M
|
|
|
Feb 14, 2025
Q4 2024
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
- |
1.32K+ 0.12% |
$224 - $369
|
1.06M
$9.65M
|
|
|
Feb 14, 2025
Q4 2024
|
Mirae Asset Global Etfs Holdings Ltd.
Central, K3 |
BUY
|
- |
1.22K+ 4.58% |
$207 - $340
|
27.8K
$253K
|
|
|
Feb 13, 2025
Q4 2024
|
Invesco Ltd.
Atlanta, GA |
BUY
|
- |
972+ 4.29% |
$165 - $272
|
23.6K
$215K
|
|
|
Jan 17, 2025
Q4 2024
|
Nisa Investment Advisors, LLC
|
BUY
|
- |
463+ 1251.35% |
$78.7 - $130
|
500
$4.56K
|
|
|
Feb 07, 2025
Q4 2024
|
Ever Source Wealth Advisors, LLC
|
BUY
|
- |
119New |
$20.2 - $33.3
|
119
$1.09K
|
|
|
Feb 13, 2025
Q4 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 07, 2025
Q4 2024
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-500- 36.28% |
$85 - $140
|
878
$8.01K
|
|
|
Feb 14, 2025
Q4 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-877- 14.21% |
$149 - $246
|
5.29K
$48.3K
|
|
|
Feb 11, 2025
Q4 2024
|
Simplex Trading, LLC
|
SELL
|
- |
-3.79K- 91.27% |
$645 - $1.06K
|
363
$3.31K
|
|
|
Jan 17, 2025
Q4 2024
|
Sg Americas Securities, LLC
|
SELL
|
- |
-4.5K- 12.37% |
$765 - $1.26K
|
31.9K
$291K
|
|
|
Feb 14, 2025
Q4 2024
|
Aqr Capital Management LLC
Greenwich, CT |
SELL
|
- |
-25.3K- 46.86% |
$4.3K - $7.09K
|
28.7K
$262K
|
|
|
May 29, 2025
Q4 2024
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-46.5K- 52.96% |
$7.9K - $13K
|
41.3K
$376K
|
|
|
Feb 13, 2025
Q4 2024
|
Bank Of Montreal
Toronto, A6 |
SELL
|
- |
-65.2K- 54.66% |
$11.1K - $18.3K
|
54.1K
$494K
|
|
|
Feb 14, 2025
Q4 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-72.6K- 25.68% |
$12.3K - $20.3K
|
210K
$1.92M
|
|
|
Feb 14, 2025
Q4 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-74.8K- 16.25% |
$12.7K - $20.9K
|
386K
$3.52M
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-436K- 66.82% |
$74.1K - $122K
|
216K
$1.97M
|
|
|
Feb 14, 2025
Q4 2024
|
Samsara Bio Capital, LLC
Palo Alto, CA |
SELL
|
- |
-815K- 29.3% |
$138K - $228K
|
1.97M
$17.9M
|
|
|
Feb 11, 2025
Q4 2024
|
Sei Investments CO
Oaks, PA |
SELL
|
- |
-914K- 91.57% |
$155K - $256K
|
84.1K
$767K
|